Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZENEO Adrenaline is a prefilled, single-use, needle-free auto-injector designed for the rapid intramuscular delivery of adrenaline (epinephrine) in emergency situations such as anaphylactic shock. Developed by Crossject, this device uses high-pressure technology to propel the drug through the skin and into muscle tissue in less than a tenth of a second, ensuring reliable administration regardless of patient body type or clothing. The formulation is notable for its absence of allergenic components like sulfites and improved shelf stability. The device aims to reduce user error and needle phobia while providing life-saving treatment quickly and easily during severe allergic reactions[1][2][3][4][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZENEO Adrenaline.